Embolization Agents Market is expected to reach US$ 4,525.75 million by 2028

Coil Segment to Lead Embolization Agents Market During 2021–2028

According to our latest study on “Embolization Agents Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Application, and End User,” the market is projected to reach US$ 4,525.75 million by 2028 from US$ 2,714.82 million in 2021; it is expected to grow at a CAGR of 7.6% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market. The growth of the embolization agents market is primarily attributed to the rising incidence of tumors and aneurysms and the growing prevalence of hypertension, obesity, smoking, and alcoholism. However, high costs of embolization agents hinder the market growth.

Based on product, the embolization agents market is segmented into coils, beads/particles, plugs, detachable balloons, glue, sponge, liquid embolics, sclerosants, precipitating agents, and others. The beads/particles segment leads the market, whereas the coils segment is expected to register the highest CAGR in the market during the forecast period.

Medtronic; Terumo Corporation; Cook Medical LLC; Boston Scientific Corporation; Abbott; Stryker Corporation; Penumbra, Inc.; Merit Medical Systems Inc.; DePuy Synthes; and KANEKA CORPORATION are a few leading companies operating in the embolization agents market.

Embolization Agents Market, by Region, 2021 (%)

---

Embolization Agents Market Global Analysis & Forecast 2028

Download Free Sample

---

Embolization Agents Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Coils, Plugs, Beads/Particles, Detachable Balloons, Glue, Sponge, Liquid Embolics, Sclerosants, Precipitating Agents, and Others), Application (Oncology, Neurology, Urology, Cardiology, Peripheral Vascular Diseases, and Others), and End User (Hospitals, Cardiac Centers, Ambulatory Surgical Centers, and Others)

The report segments embolization agents market as follows:

The embolization agents market is segmented on the basis of product, application, and end user. Based on product, the market is segmented into coils, beads/particles, plugs, detachable balloons, glue, sponge, liquid embolics, sclerosants, precipitating agents, and others. Based on application, the market is segmented into neurology, oncology, cardiology, peripheral vascular diseases, and others. By end user, the embolization agents market is segmented into hospitals, ambulatory surgical centers, cardiac centers, and others.

By Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific (APAC)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of APAC
• Middle East and Africa (MEA)
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of MEA
• South and Central America (SCAM)
  • Brazil
  • Argentina
  • Rest of SCAM